Dipal Patel

Dipal Patel joined Valneva in November 2022.

She is an established commercial leader, who joined Valneva from GSK where she held, for more than 20 years, roles of increasing responsibilities across multiple countries including U.S., Australia, Belgium, Singapore, Thailand, and the European and emerging markets.

Her considerable experience covers commercial strategy, execution, market access and lifecycle management.

Over the last few years, Dipal has been Global Commercial Head of GSK’s shingles vaccine (Shingrix®), leading a global cross-functional team establishing it as a global brand with significant worldwide expansion.

Dipal holds an MBA.

She is an Australian national.